Various strategies, such as pharmacological inhibitors, antioxidant therapy, anti-inflammatory agents, nanoparticle-based drug delivery, and lifestyle modifications, have been identified as potential interventions to reduce HIF-1α-driven ovarian cancer progression and infertility. The gene discussed is HIF1A; the disease is Infertility.